drugset / Trial / NCT04159610

Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis

NCT04159610

RandomizedCrossoverOpen-labelTreatment

Summary

The aim of this study is to investigate the safety, tolerability and efficacy of 1% GPB Cream compared to Qbrexza® (glycopyrronium) cloth, 2.4%, for topical use under maximum use conditions.

Timeline

Start
2019-12
Primary completion
2020-10
Completion
2020-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glycopyrronium Unknown 2.4 % Topical
Subject WO3970 Unknown 1 % Topical